{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T12:48:13Z","timestamp":1777726093362,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR001105"],"award-info":[{"award-number":["UL1TR001105"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["15CVGPSD27030013"],"award-info":[{"award-number":["15CVGPSD27030013"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K08HL118131"],"award-info":[{"award-number":["K08HL118131"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000921","name":"Donald W. Reynolds Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.atherosclerosis.2017.06.007","type":"journal-article","created":{"date-parts":[[2017,6,3]],"date-time":"2017-06-03T20:01:02Z","timestamp":1496520062000},"page":"156-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Association of the serum myeloperoxidase\/high-density lipoprotein particle ratio and incident cardiovascular events in a multi-ethnic population: Observations from the Dallas Heart Study"],"prefix":"10.1016","volume":"263","author":[{"given":"Htet W.","family":"Khine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Teiber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Haley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Khera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colby R.","family":"Ayers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0164-2382","authenticated-orcid":false,"given":"Anand","family":"Rohatgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.06.007_bib1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1172\/JCI117342","article-title":"Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions","volume":"94","author":"Daugherty","year":"1994","journal-title":"J.\u00a0Clin. investigation."},{"issue":"48","key":"10.1016\/j.atherosclerosis.2017.06.007_bib2","doi-asserted-by":"crossref","first-page":"46116","DOI":"10.1074\/jbc.M209124200","article-title":"Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation","volume":"277","author":"Zhang","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2017.06.007_bib3","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1172\/JCI5549","article-title":"Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in\u00a0vitro","volume":"103","author":"Podrez","year":"1999","journal-title":"J.\u00a0Clin. investigation."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.06.007_bib4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tcm.2005.06.004","article-title":"Formation of dysfunctional high-density lipoprotein by myeloperoxidase","volume":"15","author":"Nicholls","year":"2005","journal-title":"Trends Cardiovasc. Med."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.06.007_bib5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/01.hco.0000231402.87232.aa","article-title":"Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein","volume":"21","author":"Shao","year":"2006","journal-title":"Curr. Opin. Cardiol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.06.007_bib6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/cvr\/cvn051","article-title":"Hypochlorite-modified high-density lipoprotein acts as a sink for myeloperoxidase in\u00a0vitro","volume":"79","author":"Marsche","year":"2008","journal-title":"Cardiovasc. Res."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2017.06.007_bib7","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1161\/01.ATV.18.10.1617","article-title":"Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase\/paraoxonase activities: selective action of human paraoxonase allozymes Q and R","volume":"18","author":"Aviram","year":"1998","journal-title":"Arteriosclerosis, thrombosis, Vasc. Biol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.06.007_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.atherosclerosis.2005.08.026","article-title":"Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes","volume":"187","author":"Rosenblat","year":"2006","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.06.007_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.atherosclerosis.2004.10.028","article-title":"Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine","volume":"179","author":"Rosenblat","year":"2005","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2017.06.007_bib10","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1172\/JCI67478","article-title":"Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex","volume":"123","author":"Huang","year":"2013","journal-title":"J.\u00a0Clin. investigation."},{"issue":"17","key":"10.1016\/j.atherosclerosis.2017.06.007_bib11","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1001\/jama.286.17.2136","article-title":"Association between myeloperoxidase levels and risk of coronary artery disease","volume":"286","author":"Zhang","year":"2001","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.06.007_bib12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2143\/AC.63.2.2029520","article-title":"Plasma myeloperoxidase is related to the severity of coronary artery disease","volume":"63","author":"Duzguncinar","year":"2008","journal-title":"Acta Cardiol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2017.06.007_bib13","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/01.CIR.0000090690.67322.51","article-title":"Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes","volume":"108","author":"Baldus","year":"2003","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2017.06.007_bib14","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.jacc.2007.02.040","article-title":"Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction","volume":"49","author":"Mocatta","year":"2007","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2017.06.007_bib15","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.299.11.1265","article-title":"Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk","volume":"299","author":"Bhattacharyya","year":"2008","journal-title":"Jama"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2017.06.007_bib16","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1161\/ATVBAHA.112.253930","article-title":"Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk","volume":"32","author":"Tang","year":"2012","journal-title":"Arteriosclerosis, thrombosis, Vasc. Biol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.06.007_bib17","doi-asserted-by":"crossref","first-page":"e000104","DOI":"10.1161\/JAHA.113.000104","article-title":"Diminished antioxidant activity of high-density lipoprotein-associated proteins in chronic kidney disease","volume":"2","author":"Kennedy","year":"2013","journal-title":"J.\u00a0Am. Heart Assoc."},{"key":"10.1016\/j.atherosclerosis.2017.06.007_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.atherosclerosis.2015.12.021","article-title":"Serum paraoxonase-1 activity and risk of incident cardiovascular disease: the PREVEND study and meta-analysis of prospective population studies","volume":"245","author":"Kunutsor","year":"2016","journal-title":"Atherosclerosis"},{"issue":"1\u20132","key":"10.1016\/j.atherosclerosis.2017.06.007_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cca.2008.04.001","article-title":"Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease","volume":"394","author":"Kubala","year":"2008","journal-title":"Clin. chimica acta; Int. J. Clin. Chem."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.06.007_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jacc.2007.03.033","article-title":"Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study","volume":"50","author":"Meuwese","year":"2007","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.06.007_bib21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2362.2007.01908.x","article-title":"Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes","volume":"38","author":"Ndrepepa","year":"2008","journal-title":"Eur. J. Clin. investigation."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.06.007_bib22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ahj.2007.10.017","article-title":"Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease","volume":"155","author":"Stefanescu","year":"2008","journal-title":"Am. heart J."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.06.007_bib23","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.atherosclerosis.2014.03.009","article-title":"Serum myeloperoxidase\/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease","volume":"234","author":"Haraguchi","year":"2014","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2017.06.007_bib24","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.amjcard.2004.02.058","article-title":"The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health","volume":"93","author":"Victor","year":"2004","journal-title":"Am. J. Cardiol."},{"issue":"Suppl 3","key":"10.1016\/j.atherosclerosis.2017.06.007_bib25","first-page":"A17217","article-title":"Abstract 17217: serum paraoxonase 1 (PON1) activity is associated with indices of hypertensive heart disease and cardiac remodeling in the Dallas heart study population","volume":"132","author":"Teiber","year":"2015","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2017.06.007_bib26","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1373\/clinchem.2012.199331","article-title":"Methods for measuring serum activity levels of the 192 Q and R isoenzymes of paraoxonase 1 in QR heterozygous individuals","volume":"59","author":"Teiber","year":"2013","journal-title":"Clin. Chem."},{"issue":"25","key":"10.1016\/j.atherosclerosis.2017.06.007_bib27","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2017.06.007_bib28","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1161\/ATVBAHA.107.149484","article-title":"Interleukin-18, the metabolic syndrome, and subclinical atherosclerosis: results from the Dallas heart study","volume":"27","author":"Zirlik","year":"2007","journal-title":"Arteriosclerosis, thrombosis, Vasc. Biol."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2017.06.007_bib29","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1210\/jc.2008-2406","article-title":"Sex differences in the relationship between C-reactive protein and body fat","volume":"94","author":"Khera","year":"2009","journal-title":"J.\u00a0Clin. Endocrinol. metabolism."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2017.06.007_bib30","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1161\/ATVBAHA.113.301219","article-title":"Symmetrical dimethylarginine predicts mortality in the general population: observations from the Dallas heart study","volume":"33","author":"Gore","year":"2013","journal-title":"Arteriosclerosis, thrombosis, Vasc. Biol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.06.007_bib31","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.atherosclerosis.2011.08.029","article-title":"Race-specific associations of myeloperoxidase with atherosclerosis in a population-based sample: the Dallas heart study","volume":"219","author":"Chen","year":"2011","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.06.007_bib32","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cll.2006.07.006","article-title":"Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy","volume":"26","author":"Jeyarajah","year":"2006","journal-title":"Clin. laboratory Med."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.06.007_bib33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1148\/radiol.13122707","article-title":"Abdominal aortic atherosclerosis at MR imaging is associated with cardiovascular events: the Dallas heart study","volume":"269","author":"Maroules","year":"2013","journal-title":"Radiology"},{"issue":"1\u20132","key":"10.1016\/j.atherosclerosis.2017.06.007_bib34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/biomet\/41.1-2.133","article-title":"A\u00a0distribution-free k-sample test against ordered alternatives","volume":"41","author":"Jonckheere","year":"1954","journal-title":"Biometrika"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.06.007_bib35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/01.CIR.99.2.237","volume":"99","author":"Koenig","year":"1999","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.06.007_bib36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.atherosclerosis.2011.03.015","article-title":"Interleukin 18 and coronary heart disease: prospective study and systematic review","volume":"217","author":"Jefferis","year":"2011","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.06.007_bib37","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jacc.2012.03.060","article-title":"High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis)","volume":"60","author":"Mackey","year":"2012","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"23","key":"10.1016\/j.atherosclerosis.2017.06.007_bib38","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.jacc.2008.03.016","article-title":"Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches","volume":"51","author":"deGoma","year":"2008","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.06.007_bib39","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jacc.2007.09.060","article-title":"High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies","volume":"51","author":"van der Steeg","year":"2008","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2017.06.007_bib40","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.clinbiochem.2014.04.013","article-title":"Serum paraoxonase-1 activity is more closely related to HDL particle concentration and large HDL particles than to HDL cholesterol in Type 2 diabetic and non-diabetic subjects","volume":"47","author":"Dullaart","year":"2014","journal-title":"Clin. Biochem."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.06.007_bib41","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.clinbiochem.2015.11.017","article-title":"Paraoxonase-1 activity is positively related to phospholipid transfer protein activity in type 2 diabetes mellitus: role of large HDL particles","volume":"49","author":"Dullaart","year":"2016","journal-title":"Clin. Biochem."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.06.007_bib42","first-page":"365","article-title":"Association between HDL particles size and myeloperoxidase\/paraoxonase-1 (MPO\/PON1) ratio in patients with acute coronary syndrome","volume":"51","author":"Emami Razavi","year":"2013","journal-title":"Acta medica Iran."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.06.007_bib43","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/ATVBAHA.109.199158","article-title":"The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages","volume":"30","author":"de la Llera-Moya","year":"2010","journal-title":"Arteriosclerosis, thrombosis, Vasc. Biol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.06.007_bib44","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N.\u00a0Engl. J. Med."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017302563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017302563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:37:45Z","timestamp":1758155865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915017302563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":44,"alternative-id":["S0021915017302563"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.06.007","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of the serum myeloperoxidase\/high-density lipoprotein particle ratio and incident cardiovascular events in a multi-ethnic population: Observations from the Dallas Heart Study","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}